SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-005191
Filing Date
2024-02-15
Accepted
2024-02-15 16:01:31
Documents
1
Period of Report
2024-02-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 19200
  Complete submission text file 0001127602-24-005191.txt   20786
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Davis Robert M (Reporting) CIK: 0001363076 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 24643689